Literature DB >> 31914904

Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration.

Md Ataur Rahman1, Md Rezanur Rahman2, Toyfiquz Zaman2, Md Sahab Uddin3,4, Rokibul Islam5, Mohamed M Abdel-Daim6,7, Hyewhon Rhim1,8.   

Abstract

BACKGROUND: Naturally-occurring products derived from living organisms have been shown to modulate various pharmacological and biological activities. Natural products protect against various diseases, which could be used for therapeutic assistance. Autophagy, a lysosome-mediated self-digestion pathway, has been implicated in a range of pathophysiological conditions and has recently gained attention for its role in several neurodegenerative diseases.
METHODS: In this current review, we emphasized the recent progress made in our understanding of the molecular mechanism of autophagy in different cellular and mouse models using naturally-occurring autophagy modulators for the management of several neurodegenerative diseases.
RESULTS: Accumulating evidence has revealed that a wide variety of natural compounds such as alkaloids, polyphenols, terpenoids, xanthonoids, flavonoids, lignans, disaccharides, glycolipoproteins, and saponins are involved in the modulation of the autophagy signaling pathway. These natural products have been used to treat various neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, spinocerebellar ataxia, neuroblastoma, and glioblastoma. Although a number of synthetic autophagy regulators have been recognized as encouraging neurodegenerative therapeutic candidates, natural autophagy- regulating compounds have been of further interest as potential disease therapeutics, as they cause insignificant side effects.
CONCLUSION: Existing in vitro and in vivo data are promising and highlight that naturally-occurring autophagyregulating compounds play an important role in the prevention and treatment of neurodegenerative disorders. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Natural products; autophagy; glycolipoproteins; lignans; neurodegeneration; therapeutic potential.

Year:  2020        PMID: 31914904     DOI: 10.2174/1381612826666200107142541

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

Review 1.  Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer's Disease.

Authors:  Md Ataur Rahman; M D Hasanur Rahman; A N M Mamun-Or-Rashid; Hongik Hwang; Sooyoung Chung; Bonglee Kim; Hyewhon Rhim
Journal:  Biomedicines       Date:  2022-04-29

Review 2.  Combination Drug Therapy for the Management of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Abdullah Al Mamun; Philippe Jeandet; Lotfi Aleya; Rasha A Mansouri; Ghulam Md Ashraf; Bijo Mathew; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

Review 3.  Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease.

Authors:  Abdullah Al Mamun; Md Sahab Uddin; Md Fahim Bin Bashar; Sonia Zaman; Yesmin Begum; Israt Jahan Bulbul; Md Siddiqul Islam; Md Shahid Sarwar; Bijo Mathew; Md Shah Amran; Ghulam Md Ashraf; May N Bin-Jumah; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2020-05-15       Impact factor: 6.543

Review 4.  Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Kamal Niaz; Philippe Jeandet; Christophe Clément; Bijo Mathew; Abdur Rauf; Kannan R R Rengasamy; Eduardo Sobarzo-Sánchez; Ghulam Md Ashraf; Lotfi Aleya
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

Review 5.  Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Sohanur Rahman; Tapan Behl; Philippe Jeandet; Ghulam Md Ashraf; Agnieszka Najda; May N Bin-Jumah; Hesham R El-Seedi; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

6.  A Network Pharmacology Approach to Estimate Potential Targets of the Active Ingredients of Epimedium for Alleviating Mild Cognitive Impairment and Treating Alzheimer's Disease.

Authors:  Xianwei Gao; Shengnan Li; Chao Cong; Yuejiao Wang; Lianwei Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-28       Impact factor: 2.629

Review 7.  Secondary Metabolites with Antioxidant Activities for the Putative Treatment of Amyotrophic Lateral Sclerosis (ALS): "Experimental Evidences".

Authors:  Jamire M Silva; Michelangela S C Nobre; Sonaly L Albino; Lucas L Lócio; Agnis P S Nascimento; Luciana Scotti; Marcus T Scotti; João A Oshiro-Junior; Maria C A Lima; Francisco J B Mendonça-Junior; Ricardo O Moura
Journal:  Oxid Med Cell Longev       Date:  2020-11-24       Impact factor: 6.543

Review 8.  Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer's Disease.

Authors:  Md Ataur Rahman; Md Saidur Rahman; M D Hasanur Rahman; Mohammad Rasheduzzaman; Anm Mamun-Or-Rashid; Md Jamal Uddin; Md Rezanur Rahman; Hongik Hwang; Myung-Geol Pang; Hyewhon Rhim
Journal:  Biomedicines       Date:  2020-12-24

Review 9.  Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Philippe Jeandet; Bijo Mathew; Ghulam Md Ashraf; Asma Perveen; May N Bin-Jumah; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2020-04-29       Impact factor: 6.543

Review 10.  Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson's Disease.

Authors:  Alejandra Guillermina Miranda-Díaz; Andrés García-Sánchez; Ernesto Germán Cardona-Muñoz
Journal:  Oxid Med Cell Longev       Date:  2020-08-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.